Advisory Commission on Childhood Vaccines; Notice of Meeting, 22562 [E9-11084]
Download as PDF
<![CDATA[
22562
Federal Register / Vol. 74, No. 91 / Wednesday, May 13, 2009 / Notices
Dated: May 5, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–11005 Filed 5–12–09; 8:45 am]
BILLING CODE 4140–01–M
comment period. These persons will be
allocated time as it permits.
For Further Information Contact: Anyone
requiring information regarding the ACCV
should contact Michelle Herzog, DVIC, HSB,
HRSA, Room 11C–26, 5600 Fishers Lane,
Rockville, MD 20857; telephone (301) 443–
6593 or e-mail: mherzog@hrsa.gov.
Dated: May 5, 2009.
Alexandra Huttinger,
Director, Division of Policy Review and
Coordination.
[FR Doc. E9–11084 Filed 5–12–09; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
BILLING CODE 4165–15–P
Advisory Commission on Childhood
Vaccines; Notice of Meeting
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), notice is hereby given
of the following meeting:
Name: Advisory Commission on
Childhood Vaccines (ACCV).
Date and Time: June 4, 2009, 1 pm to 5:30
pm EDT. June 5, 2009, 9 a.m. to 12 p.m. EDT.
Place: Parklawn Building (and via audio
conference call), Conference Rooms G & H,
5600 Fishers Lane, Rockville, MD 20857.
The ACCV will meet on Thursday, June 4
from 1 pm to 5:30 pm (EDT) and Friday, June
5 from 9 a.m. to 12 p.m. (EDT). The public
can join the meeting via audio conference
call by dialing 1–888–790–1959 on June 4 &
5 and providing the following information:
Leader’s Name: Dr. Geoffrey Evans.
Password: ACCV.
Agenda: The agenda items for the June
meeting will include, but are not limited to:
Updates from the Division of Vaccine Injury
Compensation (DVIC), Department of Justice,
National Vaccine Program Office,
Immunization Safety Office (Centers for
Disease Control and Prevention), National
Institute of Allergy and Infectious Diseases
(National Institutes of Health), Center for
Biologics, Evaluation and Research (Food
and Drug Administration), an update from
the IOM on the project to review adverse
effects of vaccines, and a final report from
Altarum Institute on the Petitioner’s
Satisfaction Survey. Agenda items are subject
to change as priorities dictate.
Public Comments: Persons interested in
providing an oral presentation should submit
a written request, along with a copy of their
presentation to: Michelle Herzog, DVIC,
Healthcare Systems Bureau (HSB), Health
Resources and Services Administration
(HRSA), Room 11C–26, 5600 Fishers Lane,
Rockville, Maryland 20857 or e-mail:
mherzog@hrsa.gov. Requests should contain
the name, address, telephone number, and
any business or professional affiliation of the
person desiring to make an oral presentation.
Groups having similar interests are requested
to combine their comments and present them
through a single representative. The
allocation of time may be adjusted to
accommodate the level of expressed interest.
DVIC will notify each presenter by mail or
telephone of their assigned presentation time.
Persons who do not file an advance request
for a presentation, but desire to make an oral
statement, may announce it at the time of the
VerDate Nov<24>2008
18:44 May 12, 2009
Jkt 217001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Task Force on Community Preventive
Services
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting:
Name: Task Force on Community
Preventive Services.
Times and Dates: 8 a.m.–6 p.m. EST, June
17, 2009; 8 a.m.–1 p.m. EST, June 18, 2009.
Place: Centers for Disease Control and
Prevention, 2500 Century Parkway, Room
1200/1201, Atlanta, Georgia 30345.
Status: Open to the public, limited only by
the space available.
Purpose: The mission of the Task Force is
to develop and publish the Guide to
Community Preventive Services (Community
Guide), which consists of systematic reviews
of the best available scientific evidence and
associated recommendations regarding what
works in the delivery of essential public
health services.
Topics include:
—Interventions to increase vaccination
coverage in children, adolescents, and
adults: An Update ‘‘of’’ the vaccination
requirements review
—Using Population Levels of Alcohol
Consumption as an Indicator of Excessive
Alcohol Consumption and Related Harms
—Group-based Interventions to Prevent
Adolescent Pregnancy, HIV, Other
Sexually Transmitted Infections: A
Systematic Review and Meta-analyses
—Update on the Community Guide Web site
—VPD Updates: School-based Vaccination
Programs
—Mass Media Campaigns to Increase
Physical Activity
—Technology-based Strategies to Prevent
and/or Control Obesity: Technology-based
Multi-component Counseling
Agenda items are subject to change as
priorities dictate.
Persons interested in reserving a space for
this meeting should call Charmen Crawford
at 404–498–2498.
Contact person for additional information:
Charmen Crawford, Coordinating Center for
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
Health Information and Services, National
Center for Health Marketing, Office of the
Director, 1600 Clifton Road, M/S E–69,
Atlanta, GA 30329, phone: 404–498–2498.
Dated: May 6, 2009.
James D. Seligman,
Chief Information Officer, Centers for Disease
Control and Prevention.
[FR Doc. E9–11138 Filed 5–12–09; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Board of Scientific Counselors,
National Center for Environmental
Health/Agency for Toxic Substances
and Disease Registry (BSC, NCEH/
ATSDR)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), CDC and NCEH/
ATSDR announce the following meeting
of the aforementioned committee:
Times and Dates: 8:30 a.m.–4 p.m., May
28, 2009. 8:30 a.m.–12:15 p.m., May 29, 2009.
Place: Centers for Disease Control and
Prevention, 4770 Buford Highway, Atlanta,
Georgia 30341.
Status: Open to the public, limited only by
the space available. The meeting room
accommodates approximately 75 people.
Purpose: The Secretary, Department of
Health and Human Services (HHS) and by
delegation, the Director, CDC and
Administrator, ATSDR, are authorized under
Section 301 (42 U.S.C. 241) and Section 311
(42 U.S.C. 243) of the Public Health Service
Act, as amended, to: (1) Conduct, encourage,
cooperate with, and assist other appropriate
public authorities, scientific institutions, and
scientists in the conduct of research,
investigations, experiments, demonstrations,
and studies relating to the causes, diagnosis,
treatment, control, and prevention of
physical and mental diseases and other
impairments; (2) assist states and their
political subdivisions in the prevention of
infectious diseases and other preventable
conditions and in the promotion of health
and well being; and (3) train state and local
personnel in health work. The BSC, NCEH/
ATSDR provides advice and guidance to the
Secretary, HHS; the Director, CDC and
Administrator, ATSDR; and the Director,
NCEH/ATSDR, regarding program goals,
objectives, strategies, and priorities in
fulfillment of the agency’s mission to protect
and promote people’s health. The board
provides advice and guidance that will assist
NCEH/ATSDR in ensuring scientific quality,
timeliness, utility, and dissemination of
results. The board also provides guidance to
help NCEH/ATSDR work more efficiently
and effectively with its various constituents
and to fulfill its mission in protecting
America’s health.
Matters To Be Discussed: The agenda items
will include updates by the Director of
E:\FR\FM\13MYN1.SGM
13MYN1
]]>Agencies
[Federal Register Volume 74, Number 91 (Wednesday, May 13, 2009)]
[Notices]
[Page 22562]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-11084]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Advisory Commission on Childhood Vaccines; Notice of Meeting
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), notice is hereby given of the following
meeting:
Name: Advisory Commission on Childhood Vaccines (ACCV).
Date and Time: June 4, 2009, 1 pm to 5:30 pm EDT. June 5, 2009,
9 a.m. to 12 p.m. EDT.
Place: Parklawn Building (and via audio conference call),
Conference Rooms G & H, 5600 Fishers Lane, Rockville, MD 20857.
The ACCV will meet on Thursday, June 4 from 1 pm to 5:30 pm
(EDT) and Friday, June 5 from 9 a.m. to 12 p.m. (EDT). The public
can join the meeting via audio conference call by dialing 1-888-790-
1959 on June 4 & 5 and providing the following information:
Leader's Name: Dr. Geoffrey Evans.
Password: ACCV.
Agenda: The agenda items for the June meeting will include, but
are not limited to: Updates from the Division of Vaccine Injury
Compensation (DVIC), Department of Justice, National Vaccine Program
Office, Immunization Safety Office (Centers for Disease Control and
Prevention), National Institute of Allergy and Infectious Diseases
(National Institutes of Health), Center for Biologics, Evaluation
and Research (Food and Drug Administration), an update from the IOM
on the project to review adverse effects of vaccines, and a final
report from Altarum Institute on the Petitioner's Satisfaction
Survey. Agenda items are subject to change as priorities dictate.
Public Comments: Persons interested in providing an oral
presentation should submit a written request, along with a copy of
their presentation to: Michelle Herzog, DVIC, Healthcare Systems
Bureau (HSB), Health Resources and Services Administration (HRSA),
Room 11C-26, 5600 Fishers Lane, Rockville, Maryland 20857 or e-mail:
mherzog@hrsa.gov. Requests should contain the name, address,
telephone number, and any business or professional affiliation of
the person desiring to make an oral presentation. Groups having
similar interests are requested to combine their comments and
present them through a single representative. The allocation of time
may be adjusted to accommodate the level of expressed interest. DVIC
will notify each presenter by mail or telephone of their assigned
presentation time. Persons who do not file an advance request for a
presentation, but desire to make an oral statement, may announce it
at the time of the comment period. These persons will be allocated
time as it permits.
For Further Information Contact: Anyone requiring information
regarding the ACCV should contact Michelle Herzog, DVIC, HSB, HRSA,
Room 11C-26, 5600 Fishers Lane, Rockville, MD 20857; telephone (301)
443-6593 or e-mail: mherzog@hrsa.gov.
Dated: May 5, 2009.
Alexandra Huttinger,
Director, Division of Policy Review and Coordination.
[FR Doc. E9-11084 Filed 5-12-09; 8:45 am]
BILLING CODE 4165-15-P
